Aurora Cannabis (ACB) Other Non-Current Assets (2018 - 2026)
Aurora Cannabis (ACB) posted quarterly Other Non-Current Assets of $2.6 million for Q1 2026, down 50.98% year-on-year from $5.4 million in Q1 2025, and down 23.49% on a QoQ basis from $3.4 million in Q4 2025.
Aurora Cannabis (ACB) Other Non-Current Assets (2018 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Other Non-Current Assets for 9 consecutive years, with $2.6 million the latest figure, recorded in Q1 2026.
- Quarterly Other Non-Current Assets fell 50.98% year-over-year to $2.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 million (down 50.98% YoY) and the FY2026 annual result came in at $2.6 million, down 52.87% from the prior year.
- Other Non-Current Assets declined to $2.6 million in Q1 2026 per ACB's latest filing, from $3.4 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for ACB reached as high as $13.1 million in Q4 2022 and fell as low as $2.0 million in Q1 2022.
- A 5-year average of $6.7 million and a median of $6.6 million in 2024 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets surged 529.74% — and 2026, when it slumped 50.98%.
- Year by year, Other Non-Current Assets stood at $13.1 million in 2022, then dropped by 26.89% to $9.5 million in 2023, then plunged by 31.32% to $6.6 million in 2024, then tumbled by 47.39% to $3.4 million in 2025, then retreated by 23.49% to $2.6 million in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $2.6 million, $3.4 million, and $4.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | 2.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.64 Mn |
| Dec 31, 2025 | 3.45 Mn |
| Sep 30, 2025 | 4.10 Mn |
| Jun 30, 2025 | 4.70 Mn |
| Mar 31, 2025 | 5.38 Mn |
| Dec 31, 2024 | 6.56 Mn |
| Sep 30, 2024 | 7.43 Mn |
| Jun 30, 2024 | 8.10 Mn |
| Mar 31, 2024 | 8.93 Mn |
| Dec 31, 2023 | 9.54 Mn |
| Sep 30, 2023 | 10.24 Mn |
| Jun 30, 2023 | 11.87 Mn |
| Mar 31, 2023 | 11.68 Mn |
| Dec 31, 2022 | 13.05 Mn |
| Sep 30, 2022 | 2.19 Mn |
| Jun 30, 2022 | 2.47 Mn |
| Mar 31, 2022 | 2.03 Mn |
| Dec 31, 2021 | 2.07 Mn |
| Sep 30, 2021 | 2.69 Mn |
| Jun 30, 2021 | 2.88 Mn |